These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20425270)

  • 1. Recent developments with lipoprotein-associated phospholipase A2 inhibitors.
    Chauffe RJ; Wilensky RL; Mohler ER
    Curr Atheroscler Rep; 2010 Jan; 12(1):43-7. PubMed ID: 20425270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical role of lipoprotein-associated phospholipase A2].
    Miklishanskaia SV; Liakishev AA; Kukharchuk VV
    Kardiologiia; 2013; 53(3):59-70. PubMed ID: 23548429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic modulation of lipoprotein-associated phospholipase A2 (Lp-PLA2).
    Tselepis AF; Rizzo M; Goudevenos IA
    Curr Pharm Des; 2011 Nov; 17(33):3656-61. PubMed ID: 22074435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A2 in oxidized human low density lipoprotein.
    Davis B; Koster G; Douet LJ; Scigelova M; Woffendin G; Ward JM; Smith A; Humphries J; Burnand KG; Macphee CH; Postle AD
    J Biol Chem; 2008 Mar; 283(10):6428-37. PubMed ID: 18165686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2: a potential therapeutic target for atherosclerosis.
    Zalewski A; Macphee C; Nelson JJ
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Dec; 5(6):527-32. PubMed ID: 16503872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein-associated phospholipase A2: a target directed at the atherosclerotic plaque.
    Suckling KE; Macphee CH
    Expert Opin Ther Targets; 2002 Jun; 6(3):309-14. PubMed ID: 12223071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A(2) and atherosclerosis.
    Wilensky RL; Macphee CH
    Curr Opin Lipidol; 2009 Oct; 20(5):415-20. PubMed ID: 19667981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2.
    Rosenson RS; Stafforini DM
    J Lipid Res; 2012 Sep; 53(9):1767-82. PubMed ID: 22665167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein associated phospholipase A2 inhibition reduces generation of oxidized fatty acids: Lp-LPA2 reduces oxidized fatty acids.
    Rosenson RS; Vracar-Grabar M; Helenowski I
    Cardiovasc Drugs Ther; 2008 Feb; 22(1):55-8. PubMed ID: 18214661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of lipoprotein-associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis.
    Vickers KC; Maguire CT; Wolfert R; Burns AR; Reardon M; Geis R; Holvoet P; Morrisett JD
    J Lipid Res; 2009 Sep; 50(9):1735-43. PubMed ID: 19359705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A(2), platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions.
    Häkkinen T; Luoma JS; Hiltunen MO; Macphee CH; Milliner KJ; Patel L; Rice SQ; Tew DG; Karkola K; Ylä-Herttuala S
    Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2909-17. PubMed ID: 10591668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simvastatin reduces lipoprotein-associated phospholipase A2 in lipopolysaccharide-stimulated human monocyte-derived macrophages through inhibition of the mevalonate-geranylgeranyl pyrophosphate-RhoA-p38 mitogen-activated protein kinase pathway.
    Song JX; Ren JY; Chen H
    J Cardiovasc Pharmacol; 2011 Feb; 57(2):213-22. PubMed ID: 21052011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of Lp-PLA2 in lipid-lowering therapy.
    Racherla S; Arora R
    Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.
    Wilensky RL; Shi Y; Mohler ER; Hamamdzic D; Burgert ME; Li J; Postle A; Fenning RS; Bollinger JG; Hoffman BE; Pelchovitz DJ; Yang J; Mirabile RC; Webb CL; Zhang L; Zhang P; Gelb MH; Walker MC; Zalewski A; Macphee CH
    Nat Med; 2008 Oct; 14(10):1059-66. PubMed ID: 18806801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amelioration of atherosclerosis in apolipoprotein E-deficient mice by inhibition of lipoprotein-associated phospholipase A2.
    Zhang H; Zhang JY; Sun TW; Shen DL; He F; Dang YH; Li L
    Clin Invest Med; 2013 Feb; 36(1):E32-41. PubMed ID: 23374598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lipoprotein-associated phospholipase a₂ as a marker and potential therapeutic target in atherosclerosis.
    Stewart RA; White HD
    Curr Atheroscler Rep; 2011 Apr; 13(2):132-7. PubMed ID: 21207201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lp-PLA2, a biomarker of vascular inflammation and vulnerability of atherosclerosis plaques].
    Bonnefont-Rousselot D
    Ann Pharm Fr; 2016 May; 74(3):190-7. PubMed ID: 26499399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation.
    Gonçalves I; Edsfeldt A; Ko NY; Grufman H; Berg K; Björkbacka H; Nitulescu M; Persson A; Nilsson M; Prehn C; Adamski J; Nilsson J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1505-12. PubMed ID: 22499993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simvastatin reduces expression and activity of lipoprotein-associated phospholipase A(2) in the aorta of hypercholesterolaemic atherosclerotic rabbits.
    Qiao Z; Ren J; Chen H
    J Int Med Res; 2009; 37(4):1029-37. PubMed ID: 19761685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.